Results 131 to 140 of about 25,511 (229)

Immunogenicity of measles-rubella vaccine administered under India's Universal Immunization Programme in the context of measles-rubella elimination goal: A longitudinal study. [PDF]

Indian J Med Res, 2023
Verma SK, Shah D, Singh A, Singh PK, Das S, Gupta P.   +5 more
europepmc   +1 more source

Buschke-Lowenstein tumor treated with intralesional measles, mumps, and rubella vaccine. [PDF]

Indian J Sex Transm Dis AIDS, 2022
Deshmukh A, Gulanikar A, Pathrikar S, Pawar SS.   +3 more
europepmc   +1 more source

Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]

Public Health Pract (Oxf), 2023
Guo A, Leung J, Ayers T, Fields VS, Safi H, Waters C, Curns AT, Routh JA, Haselow DT, Marlow MA, Marin M.   +10 more
europepmc   +1 more source

Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine. [PDF]

Vaccine
Quach HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, Poland GA, Kennedy RB.   +5 more
europepmc   +1 more source

Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study. [PDF]

Cureus
Pula JR, K P, Patel RM, Mankar SV, Vinayak S, Ray S, Bhattacharjee S, Jain P, Bhatia P, Dutta T, Mahajan M.   +10 more
europepmc   +1 more source

Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]

Ther Adv Vaccines Immunother, 2022
Otiv M, Botre A, Shah P.
europepmc   +1 more source

Mumps Outbreak in Shivamogga, India (2023-2024): Age-Specific Attack Rates, Complications, and an Economic Case for Measles-Mumps-Rubella Vaccine Inclusion in the Universal Immunization Programme. [PDF]

Cureus
Gireesh S, Sakaleshpur Kumar V, S R R.
europepmc   +1 more source

Corrigendum to "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo" [Vaccine: X 9 (2021) 100127]. [PDF]

Vaccine X, 2022
Cheng A, Frey K, Mwamba GN, McCarthy KA, Hoff NA, Rimoin AW.   +5 more
europepmc   +1 more source

High measles and rubella vaccine coverage and seroprevalence among Zambian children participating in a measles and rubella supplementary immunization activity. [PDF]

PLOS Glob Public Health
Prosperi C, Truelove S, Carcelen AC, Chongwe G, Mwansa FD, Ndubani P, Simulundu E, Bwalya IC, Hamahuwa M, Kapungu K, Matakala KH, Musukwa G, Mutale I, Betha E, Chaavwa N, Kampamba L, Matoba J, Munachoonga P, Mufwambi W, Situtu K, Thuma PE, Sakala C, Kayeye P, Winter AK, Ferrari MJ, Moss WJ, Mutembo S.   +26 more
europepmc   +1 more source